|
|
|
Royal Pharmaceutical Society of Great Britain, London, london
04/06/08
10.00 Introduction to personalised medicines 10.30 New developments in methods of genetic analysis 11.00 Statistical issues in pharmacogenetics 11.30 You have found a genetic association - now what? 12.00 Lunch 13.30 Does genetic testing have a role in current drug therapy - Cardiovascular drugs 14.00 Does genetic testing have a role in current drug therapy – Anticancer drugs 14.30 Does genetic testing have a role in current drug therapy – CNS drugs 15.00 Pharmacogenetics - A view from industry15.30 Coffee break 16.00 Regulatory implications of pharmacogenetics 16.30 Concluding remarks
|
|
|
|
|
|
Organized by:
|
|
Royal Pharmaceutical Society of Great Britain, London |
|
Invited Speakers:
|
|
Geoff Tucker, University of Sheffield Ian Craig, Kings College London Anke-Hilse Maitland-van-der Zee, University of Utrecht Clive Bowman, GlaxoSmithKline Munir Pirmohammed, University of Liverpool Matthias Schwab, Inst Klin Pharmakol Stuttgart Kathy Aitchison, Kings College London Duncan McHale, Pfizer Krishna Prasad, MHRA
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
Registration:
|
|
09.15 Registration and coffee
|
|
E-mail:
|
|
science@rpsgb
|
|
|
|
|
|
|
|